283 related articles for article (PubMed ID: 31786262)
1. Small molecules for great solutions: Can nitric oxide-releasing nanomaterials overcome drug resistance in chemotherapy?
Pieretti JC; Pelegrino MT; Nascimento MHM; Tortella GR; Rubilar O; Seabra AB
Biochem Pharmacol; 2020 Jun; 176():113740. PubMed ID: 31786262
[TBL] [Abstract][Full Text] [Related]
2. Sensitizing activities of nitric oxide donors for cancer resistance to anticancer therapeutic drugs.
Bonavida B
Biochem Pharmacol; 2020 Jun; 176():113913. PubMed ID: 32173364
[TBL] [Abstract][Full Text] [Related]
3. State of the art, challenges and perspectives in the design of nitric oxide-releasing polymeric nanomaterials for biomedical applications.
Seabra AB; Justo GZ; Haddad PS
Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1370-9. PubMed ID: 25636971
[TBL] [Abstract][Full Text] [Related]
4. Combination of nitric oxide and drug delivery systems: tools for overcoming drug resistance in chemotherapy.
Kim J; Yung BC; Kim WJ; Chen X
J Control Release; 2017 Oct; 263():223-230. PubMed ID: 28034787
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide donors for prostate and bladder cancers: Current state and challenges.
Seabra AB; Durán N
Eur J Pharmacol; 2018 May; 826():158-168. PubMed ID: 29501865
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional nanoplatforms co-delivering combinatorial dual-drug for eliminating cancer multidrug resistance.
Wei X; Song M; Li W; Huang J; Yang G; Wang Y
Theranostics; 2021; 11(13):6334-6354. PubMed ID: 33995661
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide releasing nanomaterials for cancer treatment: current status and perspectives.
Seabra AB; de Lima R; Calderón M
Curr Top Med Chem; 2015; 15(4):298-308. PubMed ID: 25579351
[TBL] [Abstract][Full Text] [Related]
8. Near-infrared light switching nitric oxide nanoemitter for triple-combination therapy of multidrug resistant cancer.
Wei G; Yang G; Wei B; Wang Y; Zhou S
Acta Biomater; 2019 Dec; 100():365-377. PubMed ID: 31586724
[TBL] [Abstract][Full Text] [Related]
9. Applications for nitric oxide in halting proliferation of tumor cells.
Reynolds MM; Witzeling SD; Damodaran VB; Medeiros TN; Knodle RD; Edwards MA; Lookian PP; Brown MA
Biochem Biophys Res Commun; 2013 Feb; 431(4):647-51. PubMed ID: 23337501
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticulated Nitric Oxide Donors and their Biomedical Applications.
Seabra AB; Duran N
Mini Rev Med Chem; 2017; 17(3):216-223. PubMed ID: 27515711
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide donors: novel cancer therapeutics (review).
Huerta S; Chilka S; Bonavida B
Int J Oncol; 2008 Nov; 33(5):909-27. PubMed ID: 18949354
[TBL] [Abstract][Full Text] [Related]
12. Anticancer efficacy of a nitric oxide-modified derivative of bifendate against multidrug-resistant cancer cells.
Ren Z; Gu X; Lu B; Chen Y; Chen G; Feng J; Lin J; Zhang Y; Peng H
J Cell Mol Med; 2016 Jun; 20(6):1095-105. PubMed ID: 26864945
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of nitric oxide donors impact on cisplatin resistance in various ovarian cancer cell lines.
Kielbik M; Szulc-Kielbik I; Nowak M; Sulowska Z; Klink M
Toxicol In Vitro; 2016 Oct; 36():26-37. PubMed ID: 27427240
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase inhibitor-based cancer therapies: Considering the potential of nitric oxide (NO) to improve cancer treatment.
Ghione S; Mabrouk N; Paul C; Bettaieb A; Plenchette S
Biochem Pharmacol; 2020 Jun; 176():113855. PubMed ID: 32061562
[TBL] [Abstract][Full Text] [Related]
15. Recent advances on the development of NO-releasing molecules (NORMs) for biomedical applications.
Bhowmik R; Roy M
Eur J Med Chem; 2024 Mar; 268():116217. PubMed ID: 38367491
[TBL] [Abstract][Full Text] [Related]
16. Dual Stimuli-Responsive Controlled Release Nanocarrier for Multidrug Resistance Cancer Therapy.
Jiao X; Wang Z; Wang F; Wen Y
Chemphyschem; 2019 Dec; 20(24):3271-3275. PubMed ID: 31654459
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide: cancer target or anticancer agent?
Mocellin S
Curr Cancer Drug Targets; 2009 Mar; 9(2):214-36. PubMed ID: 19275761
[TBL] [Abstract][Full Text] [Related]
18. Advanced nitric oxide donors: chemical structure of NO drugs, NO nanomedicines and biomedical applications.
Yang Y; Huang Z; Li LL
Nanoscale; 2021 Jan; 13(2):444-459. PubMed ID: 33403376
[TBL] [Abstract][Full Text] [Related]
19. Emerging advances in P-glycoprotein inhibitory nanomaterials for drug delivery.
Kou L; Sun R; Bhutia YD; Yao Q; Chen R
Expert Opin Drug Deliv; 2018 Sep; 15(9):869-879. PubMed ID: 30169976
[TBL] [Abstract][Full Text] [Related]
20. Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling.
Frederiksen LJ; Sullivan R; Maxwell LR; Macdonald-Goodfellow SK; Adams MA; Bennett BM; Siemens DR; Graham CH
Clin Cancer Res; 2007 Apr; 13(7):2199-206. PubMed ID: 17404104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
